Skip to main content
Erschienen in: Familial Cancer 2/2018

28.07.2017 | Short Communication

Pancreatic adenocarcinoma with a germline PTEN p.Arg234Gln mutation

verfasst von: Sunao Uemura, Hiroyuki Matsubayashi, Yoshimi Kiyozumi, Katsuhiko Uesaka, Yusuke Yamamoto, Keiko Sasaki, Masato Abe, Kenichi Urakami, Masatoshi Kusuhara, Ken Yamaguchi

Erschienen in: Familial Cancer | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

A minor fraction of pancreatic ductal adenocarcinoma (PDAC) develops in association with germline mutations of the genes responsible for inherited cancer syndromes. However, the PDAC that has a germline PTEN mutation has not received much attention. Genome-wide whole exome sequencing was performed on germline and somatic DNA from an 82-year-old woman who had developed a solid pancreatic cancer but did not show characteristic findings of PTEN hamartoma tumor syndromes (PHTS). Histology of the resected pancreatic tumor showed unique PDAC findings of primarily dendriform structures and dense fibrous tissue, accompanied by multiple pancreatic intraepithelial neoplasias in the vicinity. The tumor immunohistochemistry revealed a loss of PTEN expression and overexpression of TP53. Exome sequencing revealed a K-ras mutation (p.Gly12Val). Germline exome sequencing revealed a missense mutation of PTEN (p.Arg234Gln), a rare variant with a reported association with cancer development but not with other PHTS phenotypes. To our knowledge, this is the first report of PDAC associated with a germline PTEN mutation, particularly a rare variant (p.Arg234Gln) with cancer risks.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Spinelli L, Black FM, Berg JN et al (2015) Functionally distinct groups of inherited PTEN mutations in autism and tumour syndromes. J Med Genet 52:128–134CrossRefPubMed Spinelli L, Black FM, Berg JN et al (2015) Functionally distinct groups of inherited PTEN mutations in autism and tumour syndromes. J Med Genet 52:128–134CrossRefPubMed
3.
Zurück zum Zitat Salmena L, Carracedo A, Pandolfi PP (2008) Tenets of PTEN tumor suppression. Cell 133:403–414CrossRefPubMed Salmena L, Carracedo A, Pandolfi PP (2008) Tenets of PTEN tumor suppression. Cell 133:403–414CrossRefPubMed
4.
Zurück zum Zitat Ying H, Elpek KG, Vinjamoori A et al (2011) PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-kappaB-cytokine network. Cancer Discov 1:158–169CrossRefPubMedPubMedCentral Ying H, Elpek KG, Vinjamoori A et al (2011) PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-kappaB-cytokine network. Cancer Discov 1:158–169CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Urakami K, Shimoda Y, Ohshima K et al (2016) Next generation sequencing approach for detecting 491 fusion genes from human cancer. Biomed Res 37:51–62CrossRefPubMed Urakami K, Shimoda Y, Ohshima K et al (2016) Next generation sequencing approach for detecting 491 fusion genes from human cancer. Biomed Res 37:51–62CrossRefPubMed
6.
Zurück zum Zitat Staal FJ, van der Luijt RB, Baert MR et al (2002) A novel germline mutation of PTEN associated with brain tumours of multiple lineages. Br J Cancer 86:1586–1591CrossRefPubMedPubMedCentral Staal FJ, van der Luijt RB, Baert MR et al (2002) A novel germline mutation of PTEN associated with brain tumours of multiple lineages. Br J Cancer 86:1586–1591CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Marsh DJ, Dahia PL, Coulon V et al (1998) Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation. Genes Chromosomes Cancer 21:61–69CrossRefPubMed Marsh DJ, Dahia PL, Coulon V et al (1998) Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation. Genes Chromosomes Cancer 21:61–69CrossRefPubMed
8.
Zurück zum Zitat Caserta E, Egriboz O, Wang H et al (2015) Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo. Genes Dev 29:1707–1720CrossRefPubMedPubMedCentral Caserta E, Egriboz O, Wang H et al (2015) Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo. Genes Dev 29:1707–1720CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Smyrk TC, Watson P, Kaul K et al (2001) Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer 91:2417–2422CrossRefPubMed Smyrk TC, Watson P, Kaul K et al (2001) Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer 91:2417–2422CrossRefPubMed
10.
Metadaten
Titel
Pancreatic adenocarcinoma with a germline PTEN p.Arg234Gln mutation
verfasst von
Sunao Uemura
Hiroyuki Matsubayashi
Yoshimi Kiyozumi
Katsuhiko Uesaka
Yusuke Yamamoto
Keiko Sasaki
Masato Abe
Kenichi Urakami
Masatoshi Kusuhara
Ken Yamaguchi
Publikationsdatum
28.07.2017
Verlag
Springer Netherlands
Erschienen in
Familial Cancer / Ausgabe 2/2018
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-017-0025-7

Weitere Artikel der Ausgabe 2/2018

Familial Cancer 2/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.